BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11577444)

  • 1. Molecular biological markers and micrometastasis in resected non-small-cell lung cancer. Prognostic implications.
    Osaki T; Oyama T; Inoue M; Gu CD; Kodate M; Aikawa M; So T; Mizukami M; Mitsudomi T; Yasumoto K
    Jpn J Thorac Cardiovasc Surg; 2001 Sep; 49(9):545-51. PubMed ID: 11577444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.
    Gu CD; Osaki T; Oyama T; Inoue M; Kodate M; Dobashi K; Oka T; Yasumoto K
    Ann Surg; 2002 Jan; 235(1):133-9. PubMed ID: 11753052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer.
    Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
    Ann Thorac Surg; 1999 Dec; 68(6):2053-8. PubMed ID: 10616976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis.
    Ohta Y; Oda M; Wu J; Tsunezuka Y; Hiroshi M; Nonomura A; Watanabe G
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):900-6. PubMed ID: 11689794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer.
    Osaki T; Oyama T; Gu CD; Yamashita T; So T; Takenoyama M; Sugio K; Yasumoto K
    J Clin Oncol; 2002 Jul; 20(13):2930-6. PubMed ID: 12089221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.
    Dobashi K; Sugio K; Osaki T; Oka T; Yasumoto K
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):339-46. PubMed ID: 9305185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
    Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
    J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
    Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
    Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
    Passlick B; Izbicki JR; Kubuschok B; Nathrath W; Thetter O; Pichlmeier U; Schweiberer L; Riethmüller G; Pantel K
    J Clin Oncol; 1994 Sep; 12(9):1827-32. PubMed ID: 8083707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of vascular endothelial growth factor and nm23 for the diagnosis of occult metastasis in non-small cell lung cancer.
    Ohta Y; Nozaki Z; Nozawa H; Kamesui T; Tsunezuka Y; Oda M; Watanabe G
    Jpn J Cancer Res; 2001 Mar; 92(3):361-6. PubMed ID: 11267948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
    Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
    Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
    Deng XF; Liu QX; Zhou D; Min JX; Dai JG
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study.
    Yasumoto K; Osaki T; Watanabe Y; Kato H; Yoshimura T
    Ann Thorac Surg; 2003 Jul; 76(1):194-201; discussion 202. PubMed ID: 12842539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.
    Ahrendt SA; Yang SC; Wu L; Roig CM; Russell P; Westra WH; Jen J; Brock MV; Heitmiller RF; Sidransky D
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):466-73; discussion 473-4. PubMed ID: 11882817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
    Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node occult micrometastasis in patients with non-small cell lung carcinoma: genetic diagnosis and its impact on prognosis.
    Wang Z; Liu XY; Liu FY; Chen JH
    Ai Zheng; 2003 Nov; 22(11):1204-8. PubMed ID: 14613654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of micrometastases in pN0 non-small cell lung cancer: an alternative method combining tissue microarray and immunohistochemistry.
    Franco MR; Parra ER; Takagaki TY; Soares FA; Capelozzi VL
    J Bras Pneumol; 2008 Mar; 34(3):129-35. PubMed ID: 18392460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.